NBIX logo

Neurocrine Biosciences (NBIX) Operating expenses

annual operating expenses:

$1.74B+$285.70M(+19.67%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual total operating expenses is $1.74 billion, with the most recent change of +$285.70 million (+19.67%) on December 31, 2024.
  • During the last 3 years, NBIX annual operating expenses has risen by +$826.90 million (+90.73%).
  • NBIX annual operating expenses is now at all-time high.

Performance

NBIX Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

quarterly operating expenses:

$539.70M+$66.30M(+14.01%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly total operating expenses is $539.70 million, with the most recent change of +$66.30 million (+14.01%) on March 31, 2025.
  • Over the past year, NBIX quarterly operating expenses has increased by +$137.20 million (+34.09%).
  • NBIX quarterly operating expenses is now at all-time high.

Performance

NBIX quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

NBIX Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.7%+34.1%
3 y3 years+90.7%+78.2%
5 y5 years+213.7%+206.5%

NBIX Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+90.7%at high+83.6%
5 y5-yearat high+213.7%at high+211.6%
alltimeall timeat high+9948.0%at high>+9999.0%

NBIX Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$539.70M(+14.0%)
Dec 2024
$1.74B(+19.7%)
$473.40M(+10.3%)
Sep 2024
-
$429.30M(-0.9%)
Jun 2024
-
$433.10M(+7.6%)
Mar 2024
-
$402.50M(+12.9%)
Dec 2023
$1.45B(+19.4%)
$356.40M(+2.9%)
Sep 2023
-
$346.40M(-5.8%)
Jun 2023
-
$367.60M(-3.8%)
Mar 2023
-
$382.20M(+27.0%)
Dec 2022
$1.22B(+33.5%)
$300.90M(+2.3%)
Sep 2022
-
$294.00M(-7.8%)
Jun 2022
-
$318.70M(+5.2%)
Mar 2022
-
$302.90M(+24.2%)
Dec 2021
$911.40M(+28.7%)
$243.90M(-1.4%)
Sep 2021
-
$247.30M(+13.4%)
Jun 2021
-
$218.00M(+7.8%)
Mar 2021
-
$202.20M(+16.7%)
Dec 2020
$708.30M(+27.8%)
$173.20M(-4.6%)
Sep 2020
-
$181.60M(+2.4%)
Jun 2020
-
$177.40M(+0.7%)
Mar 2020
-
$176.10M(+12.5%)
Dec 2019
$554.10M(+36.9%)
$156.60M(+20.6%)
Sep 2019
-
$129.80M(-8.9%)
Jun 2019
-
$142.50M(+13.8%)
Mar 2019
-
$125.20M(+21.2%)
Dec 2018
$404.70M(+54.6%)
$103.33M(+7.8%)
Sep 2018
-
$95.88M(-2.1%)
Jun 2018
-
$97.90M(-9.0%)
Mar 2018
-
$107.58M(+107.2%)
Dec 2017
$261.73M(+61.2%)
$51.92M(-21.7%)
Sep 2017
-
$66.34M(+4.4%)
Jun 2017
-
$63.54M(-20.5%)
Mar 2017
-
$79.93M(+72.8%)
Dec 2016
$162.37M(+42.5%)
$46.25M(+20.3%)
Sep 2016
-
$38.44M(-8.1%)
Jun 2016
-
$41.83M(+16.7%)
Mar 2016
-
$35.86M(+16.6%)
Dec 2015
$113.97M(+76.9%)
$30.75M(-14.2%)
Sep 2015
-
$35.84M(+41.6%)
Jun 2015
-
$25.32M(+14.8%)
Mar 2015
-
$22.06M(+7.8%)
Dec 2014
$64.41M(+22.5%)
$20.47M(+21.4%)
Sep 2014
-
$16.86M(+17.4%)
Jun 2014
-
$14.36M(+12.9%)
Mar 2014
-
$12.72M(+3.8%)
Dec 2013
$52.60M(+1.8%)
$12.26M(-3.7%)
Sep 2013
-
$12.73M(-8.4%)
Jun 2013
-
$13.90M(+1.4%)
Mar 2013
-
$13.71M(+2.5%)
Dec 2012
$51.69M(+18.9%)
$13.37M(+0.3%)
Sep 2012
-
$13.32M(+11.5%)
Jun 2012
-
$11.95M(-8.5%)
Mar 2012
-
$13.06M(+22.5%)
Dec 2011
$43.49M(-7.9%)
$10.66M(-4.7%)
Sep 2011
-
$11.19M(+1.2%)
Jun 2011
-
$11.06M(+4.6%)
Mar 2011
-
$10.57M(-23.3%)
Dec 2010
$47.22M
$13.79M(+15.1%)
DateAnnualQuarterly
Sep 2010
-
$11.98M(+13.8%)
Jun 2010
-
$10.53M(-3.6%)
Mar 2010
-
$10.92M(-16.1%)
Dec 2009
$54.07M(-39.4%)
$13.02M(+25.6%)
Sep 2009
-
$10.37M(-33.7%)
Jun 2009
-
$15.63M(+3.9%)
Mar 2009
-
$15.04M(-48.8%)
Dec 2008
$89.22M(-58.2%)
$29.39M(+78.5%)
Sep 2008
-
$16.46M(-21.0%)
Jun 2008
-
$20.85M(-7.4%)
Mar 2008
-
$22.51M(-82.6%)
Dec 2007
$213.47M(+39.9%)
$129.13M(+339.7%)
Sep 2007
-
$29.37M(+6.4%)
Jun 2007
-
$27.60M(+0.8%)
Mar 2007
-
$27.38M(+6.5%)
Dec 2006
$152.55M(+2.4%)
$25.70M(-37.7%)
Sep 2006
-
$41.27M(+7.2%)
Jun 2006
-
$38.51M(-18.2%)
Mar 2006
-
$47.07M(+21.6%)
Dec 2005
$148.96M(+8.3%)
$38.70M(-2.3%)
Sep 2005
-
$39.62M(+0.5%)
Jun 2005
-
$39.42M(+26.3%)
Mar 2005
-
$31.21M(-21.3%)
Dec 2004
$137.51M(-30.5%)
$39.67M(+5.1%)
Sep 2004
-
$37.73M(+32.7%)
Jun 2004
-
$28.44M(-10.2%)
Mar 2004
-
$31.67M(-28.8%)
Dec 2003
$197.87M(+62.6%)
$44.51M(+3.9%)
Sep 2003
-
$42.83M(-25.5%)
Jun 2003
-
$57.46M(+8.3%)
Mar 2003
-
$53.07M(+17.5%)
Dec 2002
$121.66M(+42.9%)
$45.15M(+64.3%)
Sep 2002
-
$27.48M(+4.7%)
Jun 2002
-
$26.25M(+15.2%)
Mar 2002
-
$22.78M(-19.3%)
Dec 2001
$85.12M(+62.5%)
$28.24M(+38.4%)
Sep 2001
-
$20.40M(+7.8%)
Jun 2001
-
$18.92M(+7.7%)
Mar 2001
-
$17.57M(+13.8%)
Dec 2000
$52.39M(+35.0%)
$15.44M(-0.9%)
Sep 2000
-
$15.57M(+43.4%)
Jun 2000
-
$10.86M(+3.2%)
Mar 2000
-
$10.52M(+7.4%)
Dec 1999
$38.80M(+28.9%)
$9.80M(-8.4%)
Sep 1999
-
$10.70M(+12.6%)
Jun 1999
-
$9.50M(+9.2%)
Mar 1999
-
$8.70M(+1.2%)
Dec 1998
$30.10M(+11.9%)
$8.60M(-1.1%)
Sep 1998
-
$8.70M(+42.6%)
Jun 1998
-
$6.10M(-11.6%)
Mar 1998
-
$6.90M(-12.7%)
Dec 1997
$26.90M(+55.5%)
$7.90M(+14.5%)
Sep 1997
-
$6.90M(+15.0%)
Jun 1997
-
$6.00M(+1.7%)
Mar 1997
-
$5.90M(-6.3%)
Dec 1996
$17.30M
$6.30M(+57.5%)
Sep 1996
-
$4.00M(-9.1%)
Jun 1996
-
$4.40M(+69.2%)
Mar 1996
-
$2.60M

FAQ

  • What is Neurocrine Biosciences annual total operating expenses?
  • What is the all time high annual operating expenses for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual operating expenses year-on-year change?
  • What is Neurocrine Biosciences quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly operating expenses year-on-year change?

What is Neurocrine Biosciences annual total operating expenses?

The current annual operating expenses of NBIX is $1.74B

What is the all time high annual operating expenses for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total operating expenses is $1.74B

What is Neurocrine Biosciences annual operating expenses year-on-year change?

Over the past year, NBIX annual total operating expenses has changed by +$285.70M (+19.67%)

What is Neurocrine Biosciences quarterly total operating expenses?

The current quarterly operating expenses of NBIX is $539.70M

What is the all time high quarterly operating expenses for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total operating expenses is $539.70M

What is Neurocrine Biosciences quarterly operating expenses year-on-year change?

Over the past year, NBIX quarterly total operating expenses has changed by +$137.20M (+34.09%)
On this page